Xin Han

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Prostate Cancer

Immune Response

Top Venues

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Xin Han, Lijie Zhao, Weiguo Xiang, Bukeyan Miao, Chong Qin, Mi Wang, Tianfeng Xu, Donna McEachern, Jianfeng Lu, Yu Wang, Hoda Metwally, Chao-Yie Yang, Paul D Kirchhoff, Lu Wang, Aleksas Matvekas, John Takyi-Williams, Bo Wen, Duxin Sun, Mark Ator, Robert Mckean, Shaomeng Wang
Discovery of ARD-2051 as a Potent and Orally Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer. Journal of medicinal chemistry (2023)
Xin Han, Lijie Zhao, Weiguo Xiang, Chong Qin, Bukeyan Miao, Donna McEachern, Yu Wang, Hoda Metwally, Lu Wang, Aleksas Matvekas, Bo Wen, Duxin Sun, Shaomeng Wang
Strategies toward Discovery of Potent and Orally Bioavailable Proteolysis Targeting Chimera Degraders of Androgen Receptor for the Treatment of Prostate Cancer. Journal of medicinal chemistry 64 (17) (2021)
Weiguo Xiang, Lijie Zhao, Xin Han, Chong Qin, Bukeyan Miao, Donna McEachern, Yu Wang, Hoda Metwally, Paul D Kirchhoff, Lu Wang, Aleksas Matvekas, Miao He, Bo Wen, Duxin Sun, Shaomeng Wang
Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer. Journal of medicinal chemistry 64 (18) (2021)